• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CDC EID: Genesis and Spread of Novel Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Genotype EA-2023-DG Reassortant, Western Europe

Commonground

Senior Moderator
Early Release
Volume 31, Number 6—June 2025

Abstract


In Europe, highly pathogenic avian influenza (HPAI) virus circulates in avian wildlife, undergoing frequent reassortment, sporadic introductions in domestic birds, and spillover to mammals. An H5N1 clade 2.3.4.4b reassortant, EA-2023-DG, affecting wild and domestic birds was detected in western Europe in November 2023. Six of its RNA segments came from the EA-2021-AB genotype, but the polymerase basic 2 and polymerase acidic segments originated from low pathogenicity avian influenza viruses. Discrete phylogeographic analyses of concatenated genomes and single polymerase basic 2 and polymerase acidic segments suggested reassortment in summer 2023 near the southwestern Baltic Sea. Subsequent continuous phylogeographic analysis of all concatenated EA-2023-DG genomes highlighted circulation in northwestern Europe until June 2024 and long-distance dispersal toward France, Norway, England, Slovakia, Switzerland, and Austria. Those results illustrate the value of phylodynamic approaches to investigate emergence of novel avian influenza virus variants, trace their subsequent dispersal history, and provide vital clues for informing outbreak prevention and intervention policies.

Continued: https://wwwnc.cdc.gov/eid/article/31/6/24-1870_article
 
from above:

In vivo experiments following up on the emergence of HPAIV H5N1 in cattle in the United States (35), and its subsequent spillover to other mammals, including cats (35) and exposed humans (36), used an EA-2023-DG genotype virus as a model of contemporary circulating viruses in Europe. Those studies indicated that these viruses efficiently replicate in bovine mammary tissue and can produce adaptive mutations (PB2 E627K) during replication (37). Those findings underscore the value of phenotypic characterization of currently circulating H5Nx clade 2.3.4.4b viruses, including the newly emerged EA-2023-DG genotype, because the zoonotic potential of the viruses can evolve, driven and shaped by epidemiologic events that could increase the likelihood of spillover to mammals and subsequent adaptation. In response to HPAIV reassortment promiscuity resulting in fast evolution and diversification (2,6), efficient livestock and wildlife surveillance programs including a viral genomic characterization are essential.​
 
Back
Top Bottom